We have established a heart slice primary culture, which allows us to mechanically separate distinct cardiac cell populations and assay their relative mitogenic and trophic effects on cardiac myocyte proliferation and survival. Using this system, we have found that a signal(s) from the epicardium, but not the trabeculae and endocardium, is required in embryonic day 10 (E10) chick heart slices for continued cardiac myocyte proliferation and survival. An examination of potential epicardial growth or trophic factors has revealed that blockade of either retinoic acid (RA) or erythopoietin (epo) signaling from the epicardium inhibits cardiac myocyte proliferation and survival. The blockade of cardiac myocyte proliferation following administration of an RA antagonist can be rescued by exogenous epo. Conversely, the blockade of cardiac myocyte proliferation following administration of an anti-epo receptor antisera can be rescued by exogenous RA. Thus, our findings suggest that RA and epo signals work in parallel to support myocardial cell proliferation. In addition, we have found that these factors do not act directly on myocardial cells. Rather, they induce another soluble factor(s) in the epicardium that directly regulates proliferation of cardiac myocytes. We therefore postulate that the epicardium controls normal heart growth in ventricular segments of the embryonic chick heart by secreting a cardiac myocyte mitogen whose expression (or activity) is regulated by both RA and erythropoietin signaling.
Introduction
Cardiac myocytes proliferate until around birth in the mouse (Soonpaa et al., 1996) and the rat (Li et al., 1996) or hatching in the chick (Li et al., 1997) . The major proliferation-driven increase in thickness of the ventricular wall of the heart takes place from E11.5 to E14.5 in the mouse (Erokhina, 1968) , and from E8 to E14 in the chick (Rychterova, 1971 (Rychterova, , 1978 . The maintained proliferation of cardiac myocytes at these embryonic stages results in the expansion of the ventricular wall. The region of the heart that shows the highest rate of proliferation lies adjacent to the epicardium (Tokuyasu, 1990) and is termed the compact zone. Postnatally, the further increase in the size of the heart is generally attributed to hypertrophy of cardiac myocytes (Li et al., 1996 (Li et al., , 1997 Soonpaa et al., 1996) . The precise mechanisms that regulate cardiac myocyte cell proliferation are largely unknown. By analyzing the clonal progeny of chick heart cells infected with viruses encoding dominantnegative FGF-receptors, Mikawa and coworkers have demonstrated an FGF-dependent, early phase and an FGF-independent, late phase for cardiac myocyte proliferation (Mima et al., 1995) . Whereas cardiac myocytes infected at E3 with a retrovirus encoding a dominant-negative FGF-receptor gave rise to small colonies of cells relative to a control retrovirus infection, cardiac myocytes infected at E7, during the time of ventricular wall expansion, gave rise to normal size colonies. This finding suggested that only an early phase of cardiac myocyte proliferation or survival requires FGF signals (Mima et al., 1995) .
In addition to FGF, a number of other molecules have been implicated as playing a role in cardiac myocyte proliferation. Several knockout-mice have been described that show a hypoplastic cardiac phenotype associated with a thin ventricular wall, or reduced trabeculation, suggesting a possible role in cardiac myocyte proliferation for such diverse molecules as: RAR␣ (Kastner et al., 1997) , RXR␣ (Sucov et al., 1994) , VCAM-1 (Kwee et al., 1995) , ␣-integrin (Yang et al., 1995) , erythropoietin (Wu et al., 1999) , erythropoietin receptor (Wu et al., 1999) , neuregulin (Meyer and Birchmeier, 1995) , erbB2 (Lee et al., 1995) , erbB4 (Gassmann et al., 1995) , N-myc (Moens et al., 1993) , TEF-1 (Chen et al., 1994) , WT-1 (Kreidberg et al., 1993) , gp 130 (Yoshida et al., 1996) , Jak2 (Neubauer et al., 1998) , ␤-ARK (Jaber et al., 1996) , p300 (Yao et al., 1998) , Pax-3 (Li et al., 1999) , and FOG-2 (Tevosian et al., 2000) . However, it is unclear whether the affected gene products in these mutant mice directly control cardiac wall expansion per se, as it is possible that indirect mechanisms, such as a disturbance of angiogenesis or an upstream obstruction of blood flow, may result in a hypoplastic ventricular phenotype as well. In the case of VCAM-1 (Kwee et al., 1995) , ␣-integrin (Yang et al., 1995) or FOG-2 (Tevosian et al., 2000) deficient animals, it was noted that the interaction between the epicardium and the myocardium was partially disrupted. The resultant thin ventricular wall in these animals (Kwee et al., 1995; Tevosian et al., 2000; Yang et al., 1995) is consistent with the notion that communication between the epicardium and myocardium may play a role in the expansion of the ventricular wall. Indeed, an experimental delay of epicardial growth over the myocardium in chick embryos similarly leads to a thin myocardial wall (Gittenberger-de Groot et al., 2000; Perez-Pomares et al., 2002) . Interestingly the requirement for RXR␣ (Sucov et al., 1994) , gp 130 (Yoshida et al., 1996) , and the erythropoietin receptor (Wu et al., 1999) to promote the expansion of the compact zone is non-cellautonomous with respect to the cardiac myocyte lineage Fig. 1 . Cardiac myocytes proliferate in slice-culture. (A) Schematic drawing of heart slices used throughout this study. Coronal sections through the ventricular region of a E10 chick heart (HH stage 36) were dissected and cultured as an intact slice or, in some cases, cultured after removal of either the epicardium or the endocardium and trabeculae. Dotted lines indicate lines of dissection to remove either the epicardium or trabeculae and endocardium from the remaining heart slice. (B) Cardiac myocytes continue to express myosin heavy chain in explant culture. E10 chick heart slice cultures were cultured for either 2 or 4 days (2d, 4d) as indicated. The cultures were harvested and immunostained for myosin heavy chain (MHC; a and b) and assayed for DNA content by DAPI staining (c and d). Note that the vast majority of the cells in the heart slice are MHC-positive at all culture periods. (C) Cardiac myocytes in heart slice culture continue to divide for at least 4 days. E10 chick heart slices were explanted, cultured for increasing periods of time, and labeled with BrdU for 15 h prior to harvesting. The sequence of reagent additions is outlined in the upper part of the figure. Immunofluorescence for BrdU incorporation (a-c) and DAPI staining (d-f) in explants that were harvested after 2 (2d), 3 (3d), or 4 (4d) days of culture. (D) Quantitation of BrdU incorporation time course in cardiac explant cultures. (Chen et al., 1998; Hirota et al., 1999; Tran and Sucov, 1998; Wu et al., 1999) , suggesting that these signaling molecules may be required in cells other than cardiac myocytes to promote proliferation of this cell type.
To directly study the influence of the epicardium or endocardium on cardiac myocyte proliferation, we have employed a heart slice culture system that allows us to mechanically separate the epicardium or endocardium/trabeculae from the ventricular wall. We have found that a signal(s) from the epicardium, but not from the endocardium, is required for cardiac myocyte proliferation. We have investigated whether retinoic acid or erythropoietin signaling contributes to the mitogenic action of the epicardium on ventricular myocytes. Here, we show that administration of either the RAR antagonist, Ro-415253, or an anti-epo receptor antibody to heart slice cultures mimics the Fig. 2 . The epicardium, neither trabeculae nor endocardium, is required for cardiac myocyte proliferation and for survival. (A) Either intact E10 chick heart slices (a-d) or slices lacking either epicardium (e-h) or trabeculae and endocardium (i and j) were explanted, cultured for 3 or 4 days as indicated, and DNA synthesis was assayed by BrdU incorporation. The sequence of reagent additions is outlined in the upper part of the figure. Immunofluorescence for BrdU incorporation (a, b, e, f, i) and DAPI staining (c, d, g, h, j) are shown. Nuclei incorporated BrdU in both the intact heart slice (a and b) and in the heart slice lacking the endocardium and trabeculae (i), but failed to incorporate significant levels of BrdU in the heart slice lacking the epicardium (e and f). Note also that the number and appearance of the nuclei is dramatically reduced after removal of the epicardium for 4 days (h), but not after culture of either the intact heart slice (d) or after removal of the endocardium and trabeculae (j) for the same period of time. (B) Quantitation of BrdU incorporation in either the intact cardiac slice culture or in cardiac slice cultures lacking either the epicardium or the trabeculae and endocardium. Cultures were harvested after 3 or 4 days as indicated. (C) Density of nuclei in either the intact cardiac slice culture or in cardiac slice cultures lacking either the epicardium or the trabeculae and endocardium. Cultures were harvested after 3 or 4 days as indicated.
effect of removal of the epicardium and blocks cardiac myocyte proliferation. Furthermore, we demonstrate that inhibition of cardiac myocyte proliferation by Ro-415253 can be overcome by the addition of erythropoietin (epo), and that inhibition of cardiac myocyte proliferation by the anti-epo receptor antibody can be overcome by addition of exogenous RA. Finally, we show that epo and RA do not directly induce proliferation of cardiac myocytes but rather induce the secretion of a soluble cardiac myocyte mitogen from the epicardium. Together, our findings support a model in which a network of retinoic acid and epo signals in the epicardium induce the expression (or activity) of a mitogen(s) that directly regulates cardiac myocyte proliferation.
Materials and methods

Embryonic heart tissue
M159 fertilized eggs were incubated in a humidified egg incubator at 37°C. The day the incubation started was defined as E1. After 10 or 11 days of incubation, the chicken embryos were harvested and staged according to Hamburger and Hamilton (1951) . Whole hearts were dissected from HH stage 36 chick embryos on ice in PBS ϩ penicillin/streptomycin (50 g per ml each).
Light microscopic immunocytochemistry
Hearts were immersed in fixative containing 4% paraformaldehyde, 4% sucrose, 2 mM CaCl 2 , 200 mM HepesNaOH, pH 7.4, or 4% paraformaldehyde in PBS, pH 7.4, for 1 h. The fixed tissue was infiltrated with sucrose, frozen in Tissue-Tek, and 5-to 7-m cryosections were prepared and processed as described (Aaku-Saraste et al., 1997) , except that the sections were collected on Superfrost-Plus slides rather than on Gelatin-coated slides, and the blocking medium contained 3% fetal calf serum instead of 0.05% BSA. In the case of anti-BrdU immunofluorescence, cryosections were then processed as described by Novitch et al. (1996) . The primary antibodies used and their dilution/concentration were as follows: mouse mAb MF-20 against sarcomeric myosins, ascites supernatant 1:10; mouse mAb G3G4 against BrdU, hybridoma supernatant 1:200 (Developmental Studies Hybridoma Bank, Iowa City, IA). The secondary antibodies used and their dilution/concentration were as follows: TRITC-conjugated goat anti-mouse 1:200, Cy-2 or Cy-3-conjugated goat anti-mouse 1:200 (The Jackson Laboratory, Bar Harbor, ME). Sections were mounted with Moviol and/or observed directly with a Zeiss Axioskop microscope. Pictures were taken with a Toshiba 3CCD camera by using Phase 3 Imaging software (www.p3i.com).
Slice culture
Prior to the dissection, 5-10% low-melting agarose was dissolved in PBS at 65°C for 30 min. Chick hearts were removed from E10 (HH stage 36) embryos and the atria were removed. Blood cells were carefully rinsed from the lumen of the ventricles, and the hearts were briefly stored in PBS on ice. The hearts were positioned in Peel-A-Way plastic molds (VWR) in agarose initially cooled to room temperature, then rapidly chilled and solidified on ice. Blocks of agarose containing embedded hearts were cut out and fixed onto a specimen holder. The specimen holder was then cooled on ice, and sections were subsequently cut in ice-cold PBS ϩ penicillin/streptomycin with a Vibratome (Leica VT1000M). We found that the use of nonundulating razor blades (e.g., Dickinson, NJ) was critical in obtaining thin slices. We regularly cut 150-m slices because the number and quality of the slices dropped with thinner sections; however, it was possible to obtain living slices that were 50 m thin. Floating slices were then collected and typically cultured on a petri dish in a drop of at least 100 l of medium (DMEM with 10% FBS) at 37°C, 5% CO 2 . BrdU (10 m) was added to the culture medium at the indicated time points. The following reagents were used: retinoic acid was a mixture of all-trans (5 ϫ 10 Ϫ7 M) and cis-retinoic acid (5 ϫ 10 Ϫ9 M), rabbit polyclonal antiserum against the Epo Receptor or Ephrin B1 (control antiserum) was diluted 1:100 (Santa Cruz), Ro415253 (a kind gift from Dr. A. Pignatello, Hoffman-LaRoche) was employed at 1 ϫ 10 Ϫ6 M.
Epicardial cell culture and immunocytochemistry
Embryonic day 10 hearts were removed from the embryo and placed onto ice-cold PBS with penicillin/streptomycin (GIBCO). Atria and outflow tracts were removed, and the ventricular portion was cut into four pieces. Tissue chunks were cultured in DMEM/10% FBS/ pen-strep for 4 days to ensure sufficient growth of "halo" cells. After culture, the remaining heart tissue was removed. Three PBS rinses were performed after each step. Cells were fixed in 1:1 methanol:acetone for 10 min at Ϫ20°C and then blocked in 4% normal goat serum, 1% FBS, 0.1% Triton X-100 for 30 min at room temperature. Primary antibodies were diluted in PBS as follows and incubated at 4°C overnight: Wilms Tumor 1 (C-19, Santa Cruz, sc-192) 1:100, Cytokeratin (Dako, Z0622) 1:300, RALDH2 (generously provided by Dr. Ursula Dräger) 1:2000. Secondary antibodies were diluted in PBS as follows and incubated for 1 h at room temperature: biotinylated donkey anti-rabbit (Jackson, 711065152) 1:300, Texas-red-Conjugated streptavidin (Jackson, 016070084) 1:300, and Dapi 1:500. Cells were observed with a Zeiss Axioscop microscope.
Epicardial cell-conditioned medium
E10 chick heart slices were cultured in 100 l of medium, consisting of DMEM with 10% FBS, at 37°C, 5% CO 2 . After several days, the slice consisting of cardiac myocytes was removed carefully so that a "halo" of noncardiac myocyte cells that had migrated out of the slice remained attached to the culture dish. We suspect that this "halo" of noncardiac mycocytes represents epicardial cells as migration of cells out of the heart slice was not observed in slices lacking the epicardium and the cells expressed various epicardial cell markers, including Wilm's Tumor-1, RALDH-2, and cytokeratin (see Results). The epicardial cells were either maintained in the absence or presence of Epo (2 U/ml), and the epicardial cell-conditioned medium (ECCM) was harvested every 2 days.
Results
Cardiac myocytes proliferate in slice-cultures from young hearts
To monitor the effects of the epicardium or the endocardium and trabeculae on proliferation and survival of cardiac myocytes, we established an organ culture system for E10 chick hearts (i.e., HH stage 36) which have been cultured in vitro. Hearts from this stage chick embryo were excised, the atria were removed, the remaining ventricles were embedded in agarose, 100-to 150-micron transverse slices were made, and the slices were cultured. A schematic of such a slice is depicted in Fig. 1A . Similar to cardiac cell cluster cultures grown in monolayer (Polinger, 1973) , a subpopulation of cells migrated from the slices and formed a halolike structure on the periphery of the slice (data not shown). These migratory cells fail to express the cardiac myocyte marker myosin heavy chain (MHC) (data not shown), and thus appear to represent a cell population derived from nonmuscle tissue. In contrast, over 99% of the nonmigratory cells remaining in the slice were MHC-positive (Fig. 1B) . BrdU incorporation over 4 days of culture indicated that the cardiac myocytes continued to proliferate during the entire culture period ( Fig. 1C and D) .
The epicardium, but neither the trabeculae nor endocardium, is required for cardiac myocyte proliferation and survival
To examine the role of the epicardium, trabeculae, and endocardium on proliferation and survival of the myocardium, we dissected E10 chick heart slices and cultured the myocardium either with or without these adjacent tissues. As schematically outlined in Fig. 1A , either the epicardium or endocardium and trabeculae were mechanically dissected away from the remaining heart slice, which was then cultured for several days and assayed for proliferation. As the epicardium is only one to two cells thick, we were able to remove this tissue without inflicting significant damage to the majority of the myocardium. We observed that removal of the epicardium dramatically reduced the apparent number of noncardiac "halo"-forming cells that migrated out of intact slices (data not shown). This effect was not seen following removal of the endocardium and trabeculae, suggesting that the migratory cells were epicardial in origin. Removal of the epicardium resulted in a dramatic loss of BrdU incorporation in the myocardium between the second and third days of culture (Fig. 2A , compare a, c with e, g; Fig. 2B ). After 3 days of culture, the number and appearance of the nuclei in heart slices devoid of epicardium was comparable to that in intact control slices. However, after 4 days of culture, removal of the epicardium resulted in a dramatic reduction in the number of DAPI-staining nuclei (in many cases, a decrease of greater than 90% relative to the intact control slice) ( Fig. 2A , compare d with h; Fig.  2C ). It seems unlikely that the lack of BrdU incorporation throughout the myocardium in the absence of the adjacent epicardium was due to removal of some of the myocardium along with the epicardium, as cells throughout the entire thickness of the heart slice, and not just adjacent to the epicardium, are capable of incorporating BrdU in the presence but not in the absence of the adjacent epicardium ( Fig.  2A , compare a and b with e and f). In contrast to the absence of myocardial cell proliferation following removal of the epicardium, neither the proliferation nor survival of cardiac myocytes was significantly affected following the removal of the endocardium and trabeculae ( Fig. 2A , i and j; Fig. 2B and C). These findings suggest that signals from epicardial cells are required for cardiac myocyte proliferation as well as for survival.
Retinoic acid is required for cardiac myocyte proliferation and survival
To identify molecules that might be required for cardiac myocyte proliferation and survival, we examined the effect of secreted molecules known to be expressed in the epicardium. We first tested the involvement of retinoic acid (RA), which has recently been shown to be synthesized in the epicardium (Moss et al., 1998) and to modulate ventricular cell proliferation via the RXR␣ nuclear hormone receptor in a non-cell-autonomous fashion (Chen et al., 1998; Tran and Sucov, 1998) . Intact heart slices were cultured with or without the RA antagonist, Ro415253, and assayed for proliferation. Three days following administration of the RA antagonist, incorporation of BrdU into cardiac myocytes was dramatically inhibited, while the number and appearance of the nuclei was comparable to that in control slices (Fig. 3A , compare a, c with e, g; data quantified in Fig. 3B and C). After 5 days of culture, addition of Ro415253 resulted in a reduction in the number of nuclei and nuclear degradation (Fig. 3A, compare b, d , with f, h; data quantified in Fig. 3B and C) . Thus, administration of the RA antagonist, Ro415253, resulted in a phenotype similar to that following removal of the epicardium. Moss et al. (1998) have shown that cardiac myocytes respond to an RA signal, since an RA-stimulated reporter transgene is strongly expressed in the myocardium from E12.5 onwards in the mouse. Moreover, this same group showed that cardiac expression of the RA biosynthetic enzyme, RALDH2, occurs predominantly in the epicardium from E11.5 onwards, suggesting that the epicardium may be the relevant source for RA in the embryonic heart. To investigate whether RA secreted from the epicardium might directly regulate cardiac myocyte proliferation, we examined whether exogenous RA could rescue proliferation of myocardial cells in heart slices cultured in the absence of the epicardium (Fig. 4) . Administration of exogenous RA failed to rescue cardiac myocyte proliferation in heart slices cultured in the absence of the epicardium (Fig. 4A , compare e, g with f, h; and Fig. 4B ). Because RA cannot substitute for the epicardial signal that drives myocardial cell prolif- eration, yet RA signaling is apparently required for such mitogenic activity (Fig. 3) , it raised the possibility that RA might act on the epicardium itself to induce the expression (or activity) of a myocardial mitogen. Indeed, this scenario would be consistent with prior work demonstrating that RXR␣ functions in a non-cell-autonomous fashion to promote expansion of the cardiac myocyte lineage in the compact zone (Chen et al., 1998; Tran and Sucov, 1998) .
Exogenous retinoic acid does not overcome the inhibition of cardiac myocyte proliferation following removal of the epicardium
Ectopic epo administration rescues myocardial cell proliferation in heart cultures treated with the retinoic acid antagonist, Ro415253
Because erythropoietin (epo) is highly expressed in the epicardium, but not in the cardiac wall (Wu et al., 1999) , and mice lacking epo display a hypoplastic ventricle that is reminiscent of that seen in RXR knock-out mice (Sucov et al., 1994; Wu et al., 1999) , we examined whether epo and RA signaling might be involved in a common pathway regulating cardiac myocyte proliferation. To explore this issue, we examined whether the loss of cardiac myocyte proliferation in heart slice cultures treated with the RA antagonist, Ro415253, could be restored by administration of exogenous epo. E10 chick heart slices were cultured with Ro415253 in either the absence or presence of exogenous epo, and cellular proliferation was assayed by BrdU incorporation. Whereas cultures treated with Ro415253 failed to sustain myocardial DNA synthesis (Fig. 5A, c, and Fig. 5B ), those treated with Ro415253 plus epo maintained robust myocardial DNA synthesis (Fig. 5A, e, and Fig. 5B ). In addition, epo also improved the survival of cardiac myocytes following Ro415253 administration, as the number of nuclei in cultures treated with the combination of epo plus Ro415253 was not reduced as it was following Ro415253 treatment alone (Fig. 5A, compare b, d , and f). Because exogenous epo reversed the loss of myocardial DNA synthesis following Ro415253 administration, these findings suggest that epo signals work either in parallel or downstream of RA signaling to promote myocardial cell proliferation.
Exogenous epo administration, either in the absence or presence of RA, fails to rescue cardiac myocyte proliferation following removal of the epicardium
Because exogenous epo rescued cardiac myocyte proliferation in heart slices cultured in the presence of an RA antagonist, we examined whether exogenous epo could similarly rescue cardiac myocyte proliferation in heart slices cultured in the absence of the epicardium. Administration of exogenous epo, either in the absence or presence of RA, failed to promote myocardial cell proliferation in heart slices lacking the epicardium (Fig. 6A, a-h; and Fig. 6B ). These findings indicate that neither epo nor RA signaling in myocardial cells (devoid of the adjacent epicardium) is sufficient, either alone or in combination, to promote myocardial cell proliferation in the absence of the epicardium. 
Blockade of epo signaling blocks myocardial cell proliferation in heart cultures
To investigate whether epo signaling was necessary to promote cardiac myocyte proliferation in heart slice cultures, we added a polyclonal antisera directed against the epo-receptor to the cardiac explants. While control antisera (directed against ephrin B2) failed to affect cardiac myocyte proliferation, addition of anti-epo receptor antisera to the culture medium blocked the incorporation of BrdU into cardiac myoctes (Fig. 7A, a-f, and Fig. 7B ). The inhibition of myocardial DNA synthesis following addition of anti-epo Fig. 6 . Exogenous erythropoietin does not overcome the inhibition of cardiac myocyte proliferation following removal of the epicardium. (A) Either intact heart slices (a and b) or slices lacking the epicardium (c-h) were cultured for 4 days in either the absence (a-d) or the presence of erythropoietin alone (ϩEpo; e and f) or erythropoietin and retinoic acid (ϩEpoϩRA; g and h). BrdU was added to the medium for the last 2 days of culture. Immunofluorescence for BrdU (a, c, e, g) and DAPI staining (b, d, f, h) are shown. The sequence of reagent additions is outlined in the upper part of the figure. (B) Quantitation of BrdU incorporation in either intact heart slices or in heart slices lacking the epicardium that were cultured either in the absence or the presence of erythropoietin (Epo) or erythropoietin and retinoic acid (ϩEpoϩRA). Fig. 7 . Retinoic acid rescues the inhibition of cardiac myocyte proliferation by erythropoietin receptor antagonists. (A) Intact heart slices (a-h) were cultured for 4 days either in either the absence (a and b) or the presence of either anti-Ephrin B2 (EB2) antibodies (c and d), anti-erythropoietin receptor (EpoR) antibodies (e and f), or the combination of anti-erythropoietin receptor (EpoR) antibodies plus exogenous RA (g and h). BrdU was added for the last 2 days of culture. Immunofluorescence for BrdU (a, c, e, g) and DAPI staining (b, d, f, h ) is shown. The sequence of reagent additions is outlined in the upper part of the figure. Note that BrdU labeling, which is dramatically reduced in explants containing anti-EpoR antibodies (e and f) is rescued in such cultures following addition of exogenous RA (g and h). (B) Quantitation of BrdU labeling as described in (A).
receptor antisera to the heart slice cultures is consistent with prior findings that mice genetically engineered to lack either epo or the Epo receptor show a thin ventricular wall (Wu et al., 1999) , and together suggest that epo signaling is necessary for cardiac myocyte proliferation.
RA and epo act in parallel to induce a cardiac myocyte mitogen
Our findings indicate that RA and epo work either in series or in parallel to induce the synthesis of a cardiac myocyte mitogen in epicardial cells. Epo-induced mitogenic activity apparently does not require RA signals as exogenous epo is able to rescue cardiac myocyte proliferation in heart slice explants cultured in the presence of the RA antagonist, Ro415253 (Fig. 5) . To investigate whether RAinduced cardiac myocyte proliferation requires concomitant epo signaling, we evaluated whether exogenous RA was able to restore DNA synthesis in heart slice explants cultured in the presence of anti-epo receptor antisera. Addition of RA to these cultures restored myocardial cell proliferation (Fig. 7A , g and h, and Fig. 7B ), indicating that RA can promote the synthesis of a myocardial mitogen independently of epo signaling.
Epo induces the synthesis of a cardiac myocyte mitogen in epicardial cells
While epo administration can rescue myocardial cell proliferation in intact heart slices treated with a retinoic acid antagonist (Fig. 5A , e and f) and RA administration can similarly rescue cardiac myocyte proliferation in heart slices treated with an anti-epo receptor antisera (Fig. 7A, g and h) , administration of either epo or RA (Fig. 6A, e and f; Fig.  4A , f and h, respectively) or the combination of both epo and RA (Fig. 6A, g and h) failed to drive myocardial cell proliferation in the absence of the epicardium. Together, these findings suggest that epo and RA may modulate cardiac myocyte proliferation by inducing the synthesis (or activity) of a cardiac myocyte mitogen within the epicardium itself. To test this hypothesis, we prepared conditioned medium from epicardial cells that had been cultured either in the absence or presence of epo, and asked whether such conditioned medium could restore myocardial cell proliferation in heart slices devoid of epicardium. To prepare epicardial cell cultures, an intact heart slice was cultured for 2 days, allowing epicardial cells to migrate out of the slice to form a "halo" of cells surrounding the heart slice. We believe that the "halo" of migratory cells was derived from the epicardium as these migratory cells did not express the cardiac myocyte marker, myosin heavy chain (data not shown), yet expressed Wilm's Tumor-1 (WT-1), cytokeratin, and RALDH-2 (Fig. 8) , which are all highly expressed in the epicardium and not in the myocardium (Fig. 8) . Furthermore, this "halo" of migratory cells was substantially reduced in explants in which the epicardium had been removed. After 2 days in culture, the remaining heart slice was physically removed and the epicardial cells which had migrated out from the slice remained attached to the culture dish and were cultured for an additional 2 days to generate epicardial cell-conditioned medium (ECCM).
While ECCM made from untreated epicardial cells failed to restore myocardial cell proliferation in heart slices lacking epicardium (Fig. 9A, g and h, Fig. 9B ), conditioned medium made from epo-treated epicardial cultures (ECCM ϩ epo) induced robust myocardial cell proliferation in these same cultures (Fig. 9A, i and j, Fig. 9B ). It is worth noting that administration of epo in parallel with conditioned medium from non-epo-treated epicardium (ECCM) failed to induce proliferation in myocardial cultures (Fig. 9A , g and h, Fig. 9B ), indicating that the mitogenic effects of epo on the myocardium are mediated via the epicardial cells. These findings indicate that epo induces either the synthesis or activity of a soluble cardiac myocyte mitogen within epicardial cells and is consistent with the observation that the cardiac-specific expression of the epo receptor is most predominant in the epicardium (Wu et al., 1999) . We also found that treatment of epicardial cells with RA could similarly induce secretion of a cardiac myocyte mitogen into the ECCM (data not shown), consistent with the notion that epo and RA signals work in parallel to induce a cardiac myocyte mitogen in the epicardium.
Discussion
RA and epo indirectly control cardiac myocyte cell proliferation
By employing a heart slice culture system, we have demonstrated that signals from the epicardium are necessary and sufficient for myocardial cell proliferation. One such signal is apparently retinoic acid (RA), as this substance is both produced by the epicardium (Moss et al., 1998) and administration of the RA-antagonist, Ro415253, to intact heart slices can block myocardial cell proliferation (this Fig. 8 . "Halo" cells which migrate out of heart slice explants express epicardial cell markers. Sections through the ventricles of day 10 chick hearts (a-f) were immunostained for expression of either Wilm's Tumor-1 (WT-1; a), cytokeratin (c), or RALDH-2 (e). Sections were costained with DAPI to visualize the nuclei (b, d, and f). Note that immunostaining of the various antigens is greatest in the epicardial layer on the outside of the myocardium. Explants of the ventricles of day 10 chick hearts were cultured for 4 days. Explants containing the epicardium displayed a "halo" of cells which had migrated away from the explant. The majority of the explant was physically removed, and the residual cells which had migrated out of the explant to form a "halo" of cells were immunostained for expression of either Wilm's Tumor-1 (WT-1; g), cytokeratin (i), or RALDH-2 (k), or immunostained without a primary antibody to evaluate background staining (m). Cells were costained with DAPI to visualize the nuclei (h, j, l, and n). study). In addition, we have found that administration of anti-epo receptor antisera can similarly block cardiac myocyte proliferation in chick heart slice cultures. These results indicate that RA and epo signaling are necessary for cardiac myocyte proliferation in chick heart slice cultures, and are consistent with data from knockout mice embryos that suggested that these two signaling pathways might be necessary for the expansion of the ventricular wall (Sucov et al., 1994; Wu et al., 1999) . Interestingly, administration of RA and epo, either alone or in combination, to heart slices cultured in the absence of the epicardium failed to rescue cardiac myocyte proliferation in these cultures. Thus, although these signals are necessary to support proliferation of the myocardium, they are insufficient to directly drive cardiac myocyte proliferation in the absence of the epicardium. A resolution to this paradox has emerged from experiments employing medium conditioned by epicardial cells. We have found that either RA or epo induces the synthesis or activity of a cardiac myocyte mitogen in epicardial cells, which is secreted into epicardial cell conditioned medium. That RA and epo fail to directly drive myocardial cell proliferation, but rather promote the expression of a cardiac myocyte mitogen in the epicardium, is consistent with prior work indicating that both RXR␣ (Sucov et al., 1994) and the erythropoietin receptor (Wu et al., 1999) may be required in cells other than cardiac myocytes to promote expansion of the ventricular wall (Chen et al., 1998; Hirota et al., 1999; Tran and Sucov, 1998; Wu et al., 1999) . We think it is likely that RA and epo induce the synthesis of a cardiac myocyte mitogen(s) in epicardial cells via parallel pathways (outlined schematically in Fig. 10 ), as exogenous epo administration can rescue myocardial proliferation in heart slices exposed to the RA antagonist, Ro415253, and exogenous RA administration can similarly rescue cardiac myocyte proliferation in heart slices exposed to anti-epo receptor antisera.
Cardiac myocyte proliferation requires physical contact between the epicardium and myocardium
The epicardium is derived from cells of the proepicardial serosa, which lies adjacent to the septum transversum (reviewed in Manner et al., 2001 ). Proepicardial cells migrate over the outer surface of the heart to initially give rise to the epicardium, and subsequently give rise to the endothelial and smooth muscle cells of the coronary vessels and to perivascular and intramyocardial fibroblasts (Manner, 1999) . Blockade of proepicardial cell migration over the heart in manipulated chick embryos results in a thin myocardium (Gittenberger-de Groot et al., 2000; Perez-Pomares et al., 2002) , suggesting that epicardial factors are necessary for myocardial cell proliferation. Furthermore, an involvement of the epicardium in modulating cardiac myocyte proliferation has been suggested by studies in mice engineered to lack either V-cam (Kwee et al., 1995) or ␣-integrin (Yang et al., 1995) . In these genetically altered mice, there is a correlation between a loss of contact between the epicardium and the myocardium and the subsequent development of a hypoplastic ventricular wall around midgestation. However, it was not clear from any of these studies employing either manipulated chick embryos or knockout or transgenic mice whether signals from the epicardium directly regulate ventricular wall expansion per se, or if the ensuing cardiomyopathy results from a disturbance of cardiac vascularization, which originates from the epicardium (Komiyama et al., 1987) , and is therefore secondary to the decreased blood flow through the heart. Using the heart slice culture technique, we have now been able to demonstrate that soluble signals from the epicardium, induced by RA and epo are required for cellular proliferation in the myocardium. In contrast, removal of the endocardium and trabeculae from the heart slice cultures failed to affect myocardial cell proliferation.
Epicardial retinoic acid is a pleiotropic regulator of cardiac myocyte differentiation, survival, and proliferation
Recently, the epicardium has been recognized to be the principal source of RA in the developing heart, as RALDH2, the rate-limiting enzyme in RA synthesis, is highly expressed in the epicardium, but not in cardiac myocytes (Moss et al., 1998) . Although RA is solely produced in the epicardium, expression of RA-responsive reporter constructs in transgenic mice has indicated that both epicardial and myocardial cells in the heart respond to RA signaling during development (Moss et al., 1998) . In this work, we have demonstrated that, while RA signaling in the epicardium is necessary for cardiac myocyte proliferation, this is not because of a direct mitogenic effect of epicardial RA on cardiac myocytes. Although the RA-antagonist, Ro415253, dramatically reduced proliferation and the sub- Fig. 9 . Epo induces epicardial cells to secrete a soluble mitogen/survival factor for cardiac myocytes. (A) Either intact heart slices (a and b) or heart slices lacking the epicardium (c-j) were cultured for 4 days either in the absence (a-d) or the presence (e-j) of erythropoietin (Epo). Medium conditioned by either untreated epicardial cells (ECCM; g and h) or epicardial cells grown in Epo (ECCM ϩ Epo; i and j) were added to the cultures as indicated. BrdU was added for the last 2 days of culture. Immunofluorescence for BrdU (a, c, e, g, i) and DAPI staining (b, d, f, h, j) is shown. The sequence of reagent additions is outlined in the upper part of the figure. Note that BrdU labeling, which is dramatically reduced following removal of the epicardium (c and d), is rescued by the addition of epicardial cell medium conditioned in the presence of epo (ECCM ϩ Epo; i and j). Note also that the addition of epicardial cell medium conditioned in the presence of epo (ECCM ϩ Epo; i and j) reverses the reduction in the number of nuclei observed after removal of the epicardium (c and d). (B) Quantitation of BrdU labeling in either intact heart slices or in heart slices lacking the epicardium that were cultured either in the absence or presence of Epo, plus either (ECCM) or (ECCM ϩ Epo). sequent survival of cardiac myocytes in slice culture in the presence of an intact epicardium, RA by itself could not substitute for the epicardium. This finding suggests that RA secreted by the epicardium either works in concert with another epicardial factor(s) to promote myocardial cell proliferation, or that RA induces the synthesis of a distinct cardiac myocyte mitogen within the epicardium itself. The idea that RA signaling in noncardiac myocytes is necessary to promote myocardial cell proliferation is supported by two recent studies: The Chien and Sucov laboratories have recently demonstrated that mice with a cardiac myocytespecific deletion of RXR␣ fail to develop hypoplastic hearts (Chen et al., 1998) and that cardiomyocytes deficient in RXR␣ develop normally and contribute to the ventricular chamber wall in chimeric mice embryos composed of mutant and wild-type cells (Tran and Sucov, 1998) . Together with prior work indicating that RXR␣ signaling is necessary for ventricular compact zone expansion (Sucov et al., 1994) , these studies, plus our new data, indicate that RA signals work in noncardiac myocytes to promote proliferation of this cell type. Indeed, our findings are consistent with a recent study from Henry Sucov's group, which has found that RXR␣ function in the epicardium is necessary for this tissue to secrete a cardiac myocyte mitogen (Chen et al., 2002) .
Epo signaling in the epicardium induces the synthesis or expression of a cardiac myocyte mitogen in epicardial cells
Genetically engineered mice which lack either epo or the epo-receptor (epo-R) have recently been shown to develop a hypoplastic heart phenotype in addition to defects in erythropoiesis at midgestation (Wu et al., 1999) . Interestingly, the epo-receptor is expressed in the epicardium, but not in cardiac myocytes (Wu et al., 1999) , suggesting that epo signaling in cells other than cardiac myocytes are necessary for normal cardiac growth. In heart slice cultures, we found that administration of epo failed to rescue cardiac myocyte proliferation following removal of the epicardium, suggesting that epo does not directly induce myocardial cell proliferation. In contrast, conditioned medium from epotreated epicardial cells, but not from non-epo-treated epicardial cells, was able to rescue myocardial cell proliferation in heart slices that lacked the epicardium. In light of these findings, we propose that the observed hypoplastic heart phenotype in epo Ϫ/Ϫ and epo-receptor Ϫ/Ϫ mice may be due to the requirement for epo signaling in the epicardium to promote the expression or activity of a cardiac myocyte mitogen in the epicardial cells themselves.
Our results suggest that the control of myocardial growth is regulated by the activity of both RA and epo signaling pathways in the epicardium, which in turn controls the expression or activity of a myocardial mitogen(s) which is secreted by the epicardium (outlined in Fig. 10 ). That the control of myocardial cell proliferation is mediated by such a complex chain of molecular intermediaries is perhaps not surprising in view of the pleiotropic effects of RA and epo signaling, and the need for both spatially and temporally precise control of proliferation in the developing heart. In support of this hypothesis, it is known that the epo-receptor is expressed in the mouse epicardium from E10.5 to E13.5 (Wu et al., 1999) , coincident with the relatively massive growth of the ventricular wall from E11.5 in mouse (Erokhina, 1968) . In contrast, the overall responsiveness to RA signaling in the heart, as judged by expression of retinoic acid receptors, is maintained for a significantly longer period of time (Dolle et al., 1990) . Thus, by constraining the time of expression of the epo-receptor in the epicardium, the consequence of RA signaling may have far different outcomes at differing times of development within the same tissue. While our results indicate that a signal(s) from the epicardium is necessary for both the proliferation and survival of the adjacent myocardium, it is unclear whether such an epicardial signal is similarly required for survival of adult myocardial cells, or for that matter, whether adult myocardial cells, which are postmitotic, can respond to the mitogenic activity of the embryonic epicardium. Indeed, a recent study from Henry Sucov's group suggests that cardiac myocytes from postnatal mice are not responsive to the epicardial mitogen (Chen et al., 2002) .
The utilization of epo, an erythropoietic growth and differentiation factor, for regulating heart size is potentially intriguing from a physiologic and perhaps an evolutionary standpoint. We speculate that it might be advantageous to modulate the heart size of an animal according to the oxygenation status during fetal development. As it is known that epo in the liver is stimulated by Hypoxia inducible factor, HIF-1␣ (Ebert and Bunn, 1999) , it is possible that a systemic increase in epo levels, following oxygen deprivation during fetal development, could both increase rates of erythropoiesis and also increase myocardial cell proliferation. Both outcomes of epo signaling would act to improve the oxygenation status of the developing tissues, by increased erythropoiesis and by increased tissue perfusion, respectively. An understanding of how epo signaling independently regulates blood cell development or heart growth Fig. 10 . Retinoic acid and erythropoietin signaling in the epicardium work in parallel to induce the secretion of a soluble mitogen or mitogens (termed "X" and "Y") from the epicardium, which stimulates cardiac myocyte proliferation in the adjacent myocardium.
awaits further characterization of the molecular pathways regulating each of these effects.
